ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Accession Therapeutics Limited

Accession Therapeutics Limited is an active company incorporated on 15 December 2020 with the registered office located in Oxford, Oxfordshire. Accession Therapeutics Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13083685
Private limited company
Age
4 years
Incorporated 15 December 2020
Size
Unreported
Confirmation
Submitted
Dated 14 December 2024 (10 months ago)
Next confirmation dated 14 December 2025
Due by 28 December 2025 (1 month remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Building 7600c The Quorum, Alec Issigonis Way
Arc Oxford North
Oxford
OX4 2JZ
United Kingdom
Address changed on 6 Jul 2023 (2 years 3 months ago)
Previous address was Building 7600,the Quorum Alex Issigonis Way Arc Oxford North Oxford OX4 2JZ United Kingdom
Telephone
07880 787185
Email
Unreported
Website
Unreported
People
Officers
4
Shareholders
20
Controllers (PSC)
1
Director • Merchant • Chinese • Lives in China • Born in Jun 1988
Director • Scientist • Danish • Lives in UK • Born in Aug 1959
Director • British • Lives in UK • Born in Mar 1947
Director • Ceo Birk Venture • Norwegian • Lives in Norway • Born in May 1967
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Trocept Therapeutics Limited
Nicholas John Cross and Bent Karsten Jakobsen are mutual people.
Active
Unequal Ltd
Nicholas John Cross and Bent Karsten Jakobsen are mutual people.
Active
Oxford Nanosystems Ltd
Nicholas John Cross is a mutual person.
Active
Etcembly Ltd
Nicholas John Cross is a mutual person.
Active
Synaptixbio Ltd
Nicholas John Cross is a mutual person.
Active
Aigenpulse Limited
Nicholas John Cross is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£4.37M
Decreased by £8.52M (-66%)
Turnover
Unreported
Same as previous period
Employees
45
Increased by 5 (+13%)
Total Assets
£10.34M
Decreased by £6.78M (-40%)
Total Liabilities
-£1.52M
Increased by £644K (+73%)
Net Assets
£8.82M
Decreased by £7.42M (-46%)
Debt Ratio (%)
15%
Increased by 9.59% (+187%)
Latest Activity
Full Accounts Submitted
23 Days Ago on 8 Oct 2025
Confirmation Submitted
9 Months Ago on 8 Jan 2025
Full Accounts Submitted
1 Year 1 Month Ago on 17 Sep 2024
Confirmation Submitted
1 Year 10 Months Ago on 28 Dec 2023
Full Accounts Submitted
2 Years 1 Month Ago on 4 Sep 2023
Registered Address Changed
2 Years 3 Months Ago on 6 Jul 2023
Notification of PSC Statement
2 Years 9 Months Ago on 12 Jan 2023
Confirmation Submitted
2 Years 10 Months Ago on 19 Dec 2022
Registered Address Changed
3 Years Ago on 11 Oct 2022
Bent Karsten Jakobsen (PSC) Resigned
3 Years Ago on 4 May 2022
Get Credit Report
Discover Accession Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 8 Oct 2025
Statement of capital following an allotment of shares on 16 July 2025
Submitted on 21 Jul 2025
Statement of capital following an allotment of shares on 2 April 2025
Submitted on 3 Apr 2025
Confirmation statement made on 14 December 2024 with updates
Submitted on 8 Jan 2025
Statement of capital following an allotment of shares on 11 September 2024
Submitted on 26 Sep 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 17 Sep 2024
Confirmation statement made on 14 December 2023 with updates
Submitted on 28 Dec 2023
Statement of capital following an allotment of shares on 23 November 2023
Submitted on 23 Nov 2023
Statement of capital following an allotment of shares on 22 November 2023
Submitted on 22 Nov 2023
Statement of capital following an allotment of shares on 26 October 2023
Submitted on 27 Oct 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year